One stock that is currently paying a very solid trailing dividend is toll roads operator Atlas Arteria Ltd (ASX: ALX), which, according to ASX data, is now paying a dividend yield of 9.36%.

It's worth noting that the Atlas Arteria dividend is unfranked, which might make it less attractive for some investors.

Steady income streams

So what does the company do?

Atlas Arteria holds stakes in toll road businesses across France, Germany, and the US.

To be more specific, in the company's own words:

Today the Atlas Arteria Group consists of toll road businesses in France, Germany and the United States. In France, we currently own a 30.8% interest in the 2,424km motorway network located in the country's east, comprising APRR, AREA, A79 and ADELAC. In the US, we own a 66.67% interest in the Chicago Skyway, a 12.5km toll road in Chicago and have 100% of the economic interest in the Dulles Greenway, a 22km toll road in the Commonwealth of Virginia. In Germany, we own 100% of the Warnow Tunnel in the north-east city of Rostock.

In February, the company announced a net profit of $181.8 million, down from $300.2 million for the previous year, on revenue of $2.01 billion.

Chief Executive Hugh Weghby said regarding the result:

2025 was another positive year for Atlas Arteria. We delivered strong revenue growth and steady traffic performance. We continued to build and optimise our businesses to improve safety and customer experience. This performance supports a 40 cps distribution for our investors for 2025, in line with guidance. We're focused on building a resilient portfolio for the long term. That starts with getting the most out of the businesses we own – through strong performance and by pursuing value accretive growth opportunities, including preparing for upcoming French concession retenders. We're also actively looking at new opportunities across OECD markets where we see strong fundamentals and the potential to deliver attractive returns for securityholders.

Assurance on dividends

Importantly for investors, the company has signalled its intention to keep the dividend steady at 40 cents per share annually, "supported by growing free cash flow".

So, how many Atlas Arteria shares do you need to generate $10,000 per year?

Thankfully, the maths is quite simple – you need 25,000 shares multiplied by the 40 cent dividend.

This comes to a value of $106,750 at the share price of $4.27 at the time of writing, which is not too far off the 12-month low.

Atlas Arteria is valued at $6.19 billion.

The post How many shares in this high-dividend toll road stock do you need for a $10,000 income stream? appeared first on The Motley Fool Australia.

The company's shares have been trending steadily south since about the time the US launched attacks on Iran in late February. There has been no news from the company to explain the steady drift lower.

Dividend aspiration stated

The good news for shareholders, or shareholders to be, is that the company has signalled its intent to keep dividend payments steady at 40 cents per year.

In releasing its full-year results earlier this year, the company said, "Atlas Arteria continues to target future distributions of at least 40 cents per share, supported by growing free cash flow''.

At the current share price of $4.30, that equates to a hefty 9.3% dividend yield, albeit one which is unfranked.

The dividend is certainly not set in stone, but in releasing the full-year results, the company's Chief Executive Officer, Hugh Wehby, said they were travelling well.

As he said:

2025 was another positive year for Atlas Arteria. We delivered strong revenue growth and steady traffic performance. We continued to build and optimise our businesses to improve safety and customer experience. This performance supports a 40 cents per share distribution for our investors for 2025, in line with guidance. Our refreshed vision – Partnering to deliver world-class road experiences – sharpens our focus. We invest in high-quality partnerships which strengthen our competitive positions and maximise value across our businesses and portfolio. We're focused on building a resilient portfolio for the long term. That starts with getting the most out of the businesses we own – through strong performance and by pursuing value accretive growth opportunities, including preparing for upcoming French concession retenders. We're also actively looking at new opportunities across OECD markets where we see strong fundamentals and the potential to deliver attractive returns for securityholders.

The company's assets include toll road businesses across France, Germany, and the US.

Shares potentially looking cheap

Brokers following the stock also suggest there could be share price upside as well as a strong dividend yield. Of the 10 analysts surveyed by TradingView, the minimum share price target forecast is $4.31, while the highest comes in at $5.56.

The overall rating is neutral, with five of the 10 analysts giving the stock a hold recommendation.

The toll road operator was valued at $6.23 billion at the close of trade on Thursday afternoon.

The post This ASX dividend stock is now paying out more than 9% appeared first on The Motley Fool Australia.

Will the market be able to build on this on Thursday? Here are five things to watch:

ASX 200 set to fall

The Australian share market looks set to fall on Thursday despite a good night on Wall Street. According to the latest SPI futures, the ASX 200 is expected to open the day 24 points or 0.25% lower this morning. In the United States, the Dow Jones rose 2.85%, the S&P 500 jumped 2.5% and the Nasdaq stormed 2.8% higher.

CSL shares given hold rating

Bell Potter still thinks it is too early to buy CSL Ltd (ASX: CSL) shares. This morning, the broker has retained its hold rating on the biotherapeutics giant's shares with a $155.00 price target (from $175.00). It said: "The current share price reflects a materially de-rated PE multiple of ~15x our FY27 NPAT forecast, bringing CSL in line with the global biopharma peer set which also trades at an avg PE of 15x. While CSL doesn't face the same extent of generic/biosimilar competition as these biopharma peers, it does have a lower growth outlook of ~2.5% revenue CAGR (3yr) per our forecast compared to >4% avg for global peers."

Oil prices sink

ASX 200 energy shares including Beach Energy Ltd (ASX: BPT) and Santos Ltd (ASX: STO) could have a subdued session on Thursday after oil prices crashed overnight. According to Bloomberg, the WTI crude oil price is down 14.6% to US$96.42 a barrel and the Brent crude oil price is down 12% to US$96.19 a barrel. This has been driven by the signing of a ceasefire agreement between the US and Iran.

Dividend payday

Today is payday for shareholders of a number of ASX 200 shares. This includes CSL, Capricorn Metals Ltd (ASX: CMM), Qube Holdings Ltd (ASX: QUB), Brambles Ltd (ASX: BXB), SGH Ltd (ASX: SGH), Atlas Arteria Group (ASX: ALX), and NRW Holdings Limited (ASX: NWH). CSL will be rewarding its shareholders with a $1.81 per share dividend later today.

Gold price lifts

ASX 200 gold shares Newmont Corporation (ASX: NEM) and Northern Star Resources Ltd (ASX: NST) could have a good session on Thursday after the gold price pushed higher overnight. According to CNBC, the gold futures price is up 1.3% to US$4,748.1 an ounce. Traders appear to believe that falling oil prices could limit interest rate hikes, which would be good news for the precious metal.

The post 5 things to watch on the ASX 200 on Thursday appeared first on The Motley Fool Australia.

ASX 200 shares soared 2.6% to an intraday peak of 8,804 points in morning trading on Tuesday.

Leading the market today are Guzman Y Gomez Ltd (ASX: GYG) shares, up 18%, and Nextdc Ltd (ASX: NXT), up 12%.

However, some ASX shares are bucking the trend.

Here are six stocks that hit 52-week lows today.

Sonic Healthcare Ltd (ASX: SHL)

Sonic Healthcare is one of several ASX healthcare shares trading at multi-year lows these days.

The sector faces multiple headwinds, including currency changes, US tariffs, and higher labour costs and other expenses.

The Sonic Healthcare share price fell to a decade-low of $18.88 today.

This ASX healthcare share has fallen 13% in the year to date (YTD) and 21% over the past year.

Ord Minnett has a hold rating on Sonic Healthcare with a 12-month share price target of $24.

Stockland Corp Ltd (ASX: SGP)

The Stockland share price fell to a 52-week low of $4.01 today.

Stockland shares are down 30% YTD.

In a separate article, my colleague Aaron has delved into the reasons this ASX property share has tanked in 2026.

Macquarie has just reiterated its buy rating on Stockland shares with a target price of $4.42.

Endeavour Group Ltd (ASX: EDV)

The Endeavour share price fell to a record low of $3.13 on Tuesday.

Endeavour shares have tumbled 14% YTD.

Citi recently downgraded this ASX consumer staples share to a hold rating.

The broker reduced its 12-month target from $4.30 to $3.70.

Atlas Arteria Group Ltd (ASX: ALX)

The Atlas Arteria share price fell to a nine-year low of $4.21 today.

Shares in the toll roads operator have fallen 13% YTD.

Last week, Morgan Stanley maintained its hold rating on Atlas Arteria shares.

The broker reduced its share price target from $5.06 to $4.96.

Lendlease Group (ASX: LLC)

The Lendlease share price dropped to an all-time low of $3.10 on Tuesday.

The ASX real estate share has fallen 39% in 2026.

Today, Macquarie reiterated its buy rating with a 12-month price target of $4.99.

Healius Ltd (ASX: HLS)

The Healius share price dropped to a record low of 51 cents today.

The ASX healthcare share has declined 43% YTD.

Goldman Sachs reiterated its sell rating on Healius shares last month.

The broker lowered its price target from 66 cents to 57 cents.

The post 6 ASX shares hitting 52-week lows amid today's market rally appeared first on The Motley Fool Australia.

The real challenge? Figuring out which ones actually deserve a spot in your portfolio.

With market volatility shaking share prices, some high-quality income stocks are now offering seriously attractive yields. So, is this the time to pounce?

Here are two high-yield ASX dividend shares that could be worth a closer look.

Atlas Arteria Ltd (ASX: ALX)

Starting with Atlas Arteria, this infrastructure giant owns, operates, and develops toll roads across France, Germany, and the United States. These are classic defensive assets — essential infrastructure with long-term concessions and highly predictable traffic flows.

That translates into steady, recurring cash flow. Exactly the things income investors want to see.

And it shows in the dividend. The ASX dividend share is set to pay its second-half FY25 dividend next month, delivering 20 cents per security, unfranked. Based on a share price of $4.32, that works out to a trailing yield of around 9.1%, which is hard to ignore.

Of course, there are risks. Traffic volumes can be impacted by economic conditions, and the business carries debt, which can become more expensive in a higher interest rate environment. Currency fluctuations also play a role given its global operations.

But overall, Atlas Arteria's defensive profile and consistent payout history make it a compelling option for income-focused investors.

Charter Hall Long WALE REIT (ASX: CLW)

Then there's Charter Hall Long WALE REIT, a popular ASX dividend share among yield seekers.

This REIT focuses on long-term leases (WALE stands for "weighted average lease expiry"), locking in rental income over extended periods. That provides strong visibility over cash flow — a big tick for dividend reliability.

Here's where things get interesting. The price of this ASX dividend share has fallen around 17% in 2026, which has pushed the yield significantly higher. As a result, investors are now looking at a forward distribution yield of approximately 7.2%.

Management has also guided to a 2% increase in its FY26 payout to 25.5 cents per unit. That's a positive sign in a challenging environment for property stocks.

There are risks to consider, though. Like many REITs, Charter Hall Long WALE is sensitive to interest rate movements, which can impact valuations and borrowing costs. Property market conditions and tenant quality are also key factors to watch.

Still, its long lease profile and consistent distribution track record suggest this ASX dividend share remains a solid income play.

Foolish Takeaway

The bottom line? When share prices fall, yields rise and that can create opportunity. High-quality ASX dividend shares like Atlas Arteria and Charter Hall Long WALE REIT may be worth a closer look right now if you're aiming to boost your passive income stream.

The post Is it time to load up on these high-yielding ASX dividend shares? appeared first on The Motley Fool Australia.

The problem is working out how to narrow it down to the ones that suit your portfolio best.

Here are three high-yield ASX dividend shares that could offer a great passive income.

Atlas Arteria (ASX: ALX)

Atlas Arteria is a global owner, operator, and developer of toll roads, with a portfolio of five toll roads in France, Germany, and the United States.

The defensive-style asset benefits from long-term, predictable, and recurring cash flow, enabling it to pay consistently high dividends to shareholders.

Atlas is due to pay its second-half FY25 dividend to investors next month. It will pay 20 cents per security, unfranked, which equates to a trailing 9.1% dividend yield using the $4.355 share price at the time of writing. 

IPH Ltd (ASX: IPH)

IPH provides intellectual property (IP) services through a network of global brands. The group operates across ten jurisdictions in 25 countries, making it the largest IP services provider in the Asia-Pacific region. Its services cover everything from patent filing and trademarks to prosecution, portfolio management, and enforcement. A significant share of its revenue comes from the Asia-Pacific market.

The ASX dividend company consistently generates a strong cash flow from its operations. The company reported cash conversion of 101% in its first-half FY26 results.

It is this strong cash flow that has enabled the company to be an established, reliable dividend payer. It also gradually increases its dividend over time.

IPH paid an interim dividend of 10 cents per share yesterday, up 11.8% on the prior period. The company is expected to pay fully-franked dividends of 38 cents per share in FY26, translating to a dividend yield of 11.7% at IPH's $3.245 share price at the time of writing.

Nine Entertainment Co. Holdings Ltd (ASX: NEC)

Media giant Nine Entertainment underwent a strategic reshape of its business during the first half of FY26. The shift included a broad portfolio restructure involving acquisitions and asset sales, enhancing its digital and streaming revenue.

The ASX dividend company acquired QMS Media, sold Nine Radio, and restructured its NBN and Darwin TV operations. It also sold its controlling stake in property platform Domain. 

The $1.4 billion Domain deal allowed Nine to reduce debt, boost its balance sheet, and return roughly $777 million (paying a special dividend at a rate of 49 cents per share) to investors in late 2025. 

Nine is due to pay investors an unfranked interim dividend of 4.5 cents per share next month. The company is expected to pay 9 cents per share for the full year, which translates to a dividend yield of 9.88% at its current share price of 89.5 cents a piece.

The post 3 ASX dividend shares yielding 9% (or more) appeared first on The Motley Fool Australia.

Four ASX shares that have failed to follow the market higher today are listed below. Here's why they are falling:

Amplitude Energy Ltd (ASX: AEL)

The Amplitude Energy share price is down 35% to $1.72. Investors have been selling the energy company's shares following an update on drilling operations at its Isabella prospect in the Offshore Otway Basin, located in Victoria. Amplitude Energy advised that pressure depletion during the testing period does not support a commercial development of the Isabella field. As a result, the well will now be plugged and abandoned. The company's managing director and CEO, Jane Norman, said: "The result at Isabella is disappointing but geological data from this well will help inform our future exploration prospects."

Atlas Arteria Group (ASX: ALX)

The Atlas Arteria share price is down 4% to $4.34. This has been driven by the toll road operator's shares going ex-dividend this morning for its final dividend for FY 2025. Last month, when Atlas Arteria released its full-year results, it declared a final dividend of 20 cents per share. Eligible shareholders can now look forward to receiving this next month on 9 April.

Computershare Ltd (ASX: CPU)

The Computershare share price is down over 2% to $27.75. This may have been caused by a broker note out of Ord Minnett this morning. According to the note, the broker has downgraded the share registry company's shares to a hold rating with a $36.75 price target.

Woodside Energy Group Ltd (ASX: WDS)

The Woodside share price is down almost 4% to $33.45. Investors have been selling Woodside shares after oil prices sank overnight and during Asian trade on Wednesday. This has been driven by optimism that a US-Iran peace deal could be on the horizon. It isn't just Woodside shares that are falling today. The S&P/ASX 200 Energy index is down 2.3% at the time of writing.

The post Why Amplitude Energy, Atlas Arteria, Computershare, and Woodside shares are falling today appeared first on The Motley Fool Australia.

Will the market be able to build on this on Wednesday? Here are five things to watch:

ASX 200 to rise

The Australian share market looks set to rise again on Wednesday despite a poor night on Wall Street. According to the latest SPI futures, the ASX 200 is expected to open the day 67 points or 0.8% higher. In late trade in the United States, the Dow Jones is down 0.1%, the S&P 500 is down 0.35% and the Nasdaq is 0.8% lower.

Buy Life360 shares

Bell Potter sees significant value in Life360 Inc. (ASX: 360) shares at current levels. According to the note, the broker has retained its buy rating on the family safety technology company's shares with a trimmed price target of $37.75. This implies potential upside of 94% for investors. It said: "We see the release of the Q1 result on 12th May as a potential catalyst given the company has already lowered expectations and the potential of a small beat in adjusted EBITDA."

Oil prices rebound

ASX 200 energy shares Beach Energy Ltd (ASX: BPT) and Santos Ltd (ASX: STO) could have a good session on Wednesday after oil prices rebounded overnight. According to Bloomberg, the WTI crude oil price is up 4% to US$91.68 a barrel and the Brent crude oil price is up 3.6% to US$103.53 a barrel. Traders were buying oil after optimism faded over a de-escalation in the US-Iran war.

Gold price eases

ASX 200 gold shares Newmont Corporation (ASX: NEM) and Northern Star Resources Ltd (ASX: NST) could have a subdued session on Wednesday after the gold price traded lower overnight. According to CNBC, the gold futures price is down 0.2% to US$4,399 an ounce. A stronger US dollar and rate hike concerns have weighed on the gold price.

ASX 200 shares going ex-dividend

A number of ASX 200 shares are going ex-dividend this morning and could trade lower. This includes diversified mining services company Perenti Ltd (ASX: PRN), toll road operator Atlas Arteria Group (ASX: ALX) and travel agent Flight Centre Travel Group Ltd (ASX: FLT). Perenti is paying shareholders a 3.3 cents per share dividend on 9 April, Atlas Arteria is paying 20 cents per share on the same day, and Flight Centre is paying 12 cents per share on 16 April.

The post 5 things to watch on the ASX 200 on Wednesday appeared first on The Motley Fool Australia.

What did Atlas Arteria report?

• Distribution declared: 20 cents per security, unfranked
• Ex-dividend date: 25 March 2026
• Record date: 26 March 2026
• Payment date: 9 April 2026
• Distribution includes $0.19 foreign dividend and $0.01 conduit foreign income

What else do investors need to know?

The distribution relates to the second half of the 2025 financial year and is made up of two components: a $0.19 per security distribution from Atlas Arteria International Limited (ATLIX) and a $0.01 per security distribution from Atlas Arteria Limited (ATLAX), classified as conduit foreign income. This entire payout is unfranked, meaning investors will not receive franking credits on this distribution.

Further tax component details will be available on the Atlas Arteria investor centre website. Investors should also note that dividend plans are not offered for this payment.

What's next for Atlas Arteria?

Atlas Arteria remains focused on delivering stable distributions to its securityholders. The company will provide further commentary and detailed financial results with the full-year 2025 report. Investors are encouraged to refer to upcoming disclosures for updates on the group's outlook and strategy.

Atlas Arteria share price snapshot

Over the past 12 months, Atlas Arteria shares have declined 9%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 7% over the same period.

View Original Announcement

The post Atlas Arteria announces 20 cent unfranked dividend for H2 FY25 appeared first on The Motley Fool Australia.

I've had a look at three companies which appear to fit the bill pretty well.

Let's take a look.

Atlas Arteria Ltd (ASX: ALX)

This toll road company is exactly the sort of business that I think most dividend investors are searching for.

Infrastructure companies such as Atlas Arteria tend to have long-term, stable contracts, with good visibility out over potentially several years, especially on the cost front.

Atlas Arteria is currently paying a trailing dividend yield of 8.67%, which is high, but investors can take heart from what the company said when announcing its full-year results in February.

The company not only reaffirmed its final dividend of 20 cents per share but also said it would target future full-year distributions of at least 40 cents per share, "supported by free cash flow".

While that's not an ironclad guarantee, it's a strong indication that the company will continue paying out strong returns.

Helloworld Travel Ltd (ASX: HLO)

Helloworld makes the list for both strong returns and potential upside in its share price.

Shaw and Partners issued a research note this week saying that strong traveller arrival and departure numbers for January boded well for the travel operator, and they set a price target of $2.80 on the stock, compared with $1.47 currently.

The broker is predicting a dividend yield of 7.5% for the current financial year, rising to 8.2% over the subsequent two years.

Helloworld shares have been sharply sold off since the conflict in the Middle East began, and are not far off their 12-month lows of $1.30.

Perpetual Ltd (ASX: PPT)

Financial stock Perpetual is paying a 7% dividend yield, and just this week announced the $500 million sale of its wealth business to Bain Private Equity, in a move that will simplify the business.

The company said the money raised would be used to retire debt and foster organic growth in its two remaining business divisions. This surely puts the company in a good position to maintain its dividend flows.

Macquarie had a look at the wealth deal this week and put out a research note to its clients forecasting a dividend yield of 7% this financial year, which would then fall to 6.7% in FY27 and 6.4% in FY28.

The analyst team at Macquarie also has a bullish share price target of $24.60 for the stock, compared with $15.99 currently.

The post These 3 ASX stocks are paying better than 7% dividend yields appeared first on The Motley Fool Australia.

What did Atlas Arteria report?

• Proportional toll revenue grew 9.4% to $2,012.3 million
• Proportional EBITDA increased 9.3% to $1,509.9 million, with a 75.0% margin
• Statutory net profit after tax was $181.8 million, impacted by the Temporary Supplemental Tax
• Operating free cash flow per security came in at 34.9 cents
• Distribution paid and guidance for 2025 are both 40.0 cents per security

What else do investors need to know?

Atlas Arteria implemented a new leadership structure during 2025, sharpening its focus on strategic priorities. The company refreshed its executive team, appointing new CEOs at Dulles Greenway and Chicago Skyway to drive results and strategic execution.

Operationally, traffic performance was steady across the portfolio, with Dulles Greenway seeing an 8.2% increase in volume as drivers avoided congestion on alternate routes. The company also submitted a new rate case application for Dulles Greenway in December and continues to pursue growth projects in France, particularly with the A412 motorway.

What did Atlas Arteria management say?

CEO Hugh Wehby said:

2025 was another positive year for Atlas Arteria. We delivered strong revenue growth and steady traffic performance. We continued to build and optimise our businesses to improve safety and customer experience. This performance supports a 40 cps distribution for our investors for 2025, in line with guidance.

What's next for Atlas Arteria?

Looking ahead, Atlas Arteria reaffirmed its distribution guidance of 40.0 cents per security for both 2025 and 2026, with plans to maintain or exceed this level subject to ongoing business performance. The company highlighted continued growth in free cash flow and an FX hedging program to help support distributions.

Atlas Arteria remains committed to building a resilient, long-term portfolio. Its strategy focuses on optimising current operations, seeking value-accretive growth opportunities, and preparing for French concession retenders in the coming decade.

Atlas Arteria share price snapshot

Over the past 12 months, Atlas Arteria shares have declined 5%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 11% over the same period.

View Original Announcement

The post Atlas Arteria results: 2025 toll revenue climbs, 40c distribution on track appeared first on The Motley Fool Australia.

What did Atlas Arteria report?

• The French Parliament has extended the temporary supplemental tax (TST) for toll road operators for an additional year.
• The tax will again be based on a percentage of average corporate income tax due for 2025 and 2026.
• A payment of 98% of the anticipated tax is due in December 2026, with the balance in May 2027.
• Atlas Arteria reaffirmed its 2025 distribution guidance of 40 cents per security, with a target of at least 40 cps for future periods.
• Guidance remains subject to ongoing business performance, taxes, exchange rates, and other events.

What else do investors need to know?

The Finance Law for 2026, which contains the TST extension, is expected to come into effect after review by the French Constitutional Council and signing by the President in the coming weeks. This development follows Atlas Arteria's ongoing investments in toll roads across France, Germany, and the United States.

The company owns a significant stake in major French motorways, the Chicago Skyway, Dulles Greenway in Virginia, and the Warnow Tunnel in Germany. Management continues to back its distribution targets, aiming to provide stable and growing returns for investors, pending any material changes in tax or market conditions.

What did Atlas Arteria management say?

Chief Executive Officer of Atlas Arteria Hugh Wehby said:

We reiterate our 2025 distribution guidance of 40 cents per security and remain committed to delivering sustainable distributions supported by growing free cash flow.

What's next for Atlas Arteria?

Atlas Arteria will continue to monitor developments regarding the French Finance Law and will update investors once the law is enacted. The business remains focused on maintaining free cash flow and supporting distributions, while navigating potential changes in tax and regulatory settings in its key markets.

Longer term, the company aims to reinforce its position as a leading toll road operator with disciplined management and sustainable business practices across its international portfolio.

Atlas Arteria share price snapshot

Over the past 12 months, Atlas Arteria shares have declined 2%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 6% over the same period.

View Original Announcement

The post Atlas Arteria maintains distribution guidance while French tax extended appeared first on The Motley Fool Australia.

What did Atlas Arteria report?

• Q4 2025 proportionate toll revenue rose 9.5% compared to Q4 2024
• Full-year 2025 proportionate toll revenue increased 9.4% year-on-year
• APRR quarterly revenue up 1.5%, annual revenue up 2.8% (EUR terms)
• Chicago Skyway quarterly toll revenue up 10%, annual up 6.2% (USD terms)
• Traffic rose on Dulles Greenway (Q4 up 4.8%; year up 8.2%), and A79 (Q4 up 7.5%; year up 10.5%)
• Warnow Tunnel traffic fell 9.8% in Q4, revenue down 5.6% (EUR terms)

What else do investors need to know?

Steady economic conditions in France and a recovery in cross-border work permits to Geneva helped drive light vehicle traffic on major French assets. The company noted robust commuter flows, with Swiss permits up 2.9% for Geneva in the September quarter.

In the US, Chicago Skyway saw a bounce-back in both light and heavy vehicle usage after the prior period's roadworks and tariff announcements. Dulles Greenway overcame disruptions from a six-week US federal government shutdown, returning to pre-shutdown traffic growth.

Toll revenue growth benefited from toll price increases across most businesses as well as favourable foreign exchange movements. On a constant currency basis, proportionate toll revenue grew around 2.2% for Q4 and 3.0% for the full year.

What's next for Atlas Arteria?

Atlas Arteria continues to focus on disciplined management of its international toll road assets, with plans to leverage network upgrades, pricing, and customer service enhancements. The business emphasises operational efficiency and sustainable practices across its European and North American assets.

Looking ahead, the company aims to drive value by responding to regional traffic patterns, optimising toll structures, and adapting to changing commuter needs, including ongoing infrastructure maintenance and upgrades.

Atlas Arteria share price snapshot

Over the past 12 months, Altas Arteria shares have declined 1%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 5% over the same period.

View Original Announcement

The post Atlas Arteria shares: Q4 2025 toll revenue jumps 9.5% appeared first on The Motley Fool Australia.

Toll-road operator Atlas Arteria Ltd (ASX: ALX) is trading near its 52-week low at $4.87, pushing its forecast dividend yield above 8.2%. As a result, the $7 billion company sits comfortably in the top tier of Aussie dividend payers.

On the surface, the ASX 200 dividend share looks like a classic cheap and cheerful income play. Dig a little deeper, though, and the shine starts to dull.

Dividend with a warning

In a market where reliable income is getting harder to find, that sort of yield can make even cautious investors start doing mental maths. But as always, the real story isn't the size of the dividend, it's whether it can last.

First, that headline yield comes with a warning label. The ASX dividend share is paying out more in dividends than it generates in reported earnings. That's not automatically fatal – infrastructure stocks often smooth income over time – but it does raise eyebrows.

When payouts consistently outstrip profits, the margin for error shrinks fast. Investors may be enjoying generous cheques today, but they're doing so without a thick earnings cushion underneath.

Wobbling cash flows

Then there's the business of the ASX dividend share itself. Atlas Arteria owns toll roads across France, Germany and the United States. These are assets that are long-life, inflation-linked and generally predictable. But predictable doesn't mean immune.

Traffic volumes, interest rates, inflation and political decisions all feed into earnings. In calm conditions, toll roads hum along nicely. In rougher macro environments, cash flows can wobble and dividends are often the first thing analysts put under the microscope.

Finally, the share price tells its own story. Atlas Arteria hovering close to a year low suggests the market is either baking in higher risk or rotating away from yield-heavy stocks altogether. Sometimes that creates opportunity. Other times, it's a quiet warning that investors should tread carefully.

So where does that leave income seekers?

If you're a yield chaser with a strong stomach and a long-term view on toll-road resilience, this ASX dividend share might look interesting at these levels. But if you prioritise dependable, well-covered income over eye-catching yields, this could be a case of spectacle over substance.

The analysts' view on Atlas Arteria is also mixed, with most of them seeing the toll-operator as a hold. The average 12-month price target is set at $5.26, which suggests an 8% upside.

The most optimistic broker predicts a potential plus of 21%, while the most pessimistic one sees a possible loss of 3%.

The post This high-yield ASX dividend stock is near its 52-week low – is it a buy? appeared first on The Motley Fool Australia.

Will the market be able to bounce back from this on Monday? Here are five things to watch:

ASX 200 expected to rebound

The Australian share market looks set for a good start to the week following a positive finish to the last one on Wall Street on Friday. According to the latest SPI futures, the ASX 200 is expected to open the day 29 points or 0.35% higher. In the United States, the Dow Jones was up 0.5%, the S&P 500 rose 0.65%, and the Nasdaq jumped 0.8%.

Oil prices rise

It could be a good start to the week for ASX 200 energy shares such as Santos Ltd (ASX: STO) and Woodside Energy Group Ltd (ASX: WDS) after oil prices rose on Friday night. According to Bloomberg, the WTI crude oil price was up 2.35% to US$59.12 a barrel and the Brent crude oil price was up 2.2% to US$63.34 a barrel. This was driven by concerns over Iranian supply.

Buy Develop Global shares

The team at Bell Potter thinks investors should be buying Develop Global Ltd (ASX: DVP) shares. According to the note, the broker has retained its buy rating on the mining and mining services company's shares with an improved price target of $5.80. It said: "With Woodlawn de-risking behind us, DVP presents a unique small-cap copper-zinc exposure that is relatively undervalued compared with peers in the Resources space."

Gold price rises

ASX 200 gold shares Newmont Corporation (ASX: NEM) and Northern Star Resources Ltd (ASX: NST) could have a decent start to the week after the gold price pushed higher again on Friday night. According to CNBC, the gold futures price was up 0.9% to US$4,500.9 an ounce. Geopolitical concerns and US interest rate cut optimism were behind the rise.

Hold Atlas Arteria shares

Analysts at Morgans think that Atlas Arteria Group (ASX: ALX) shares are fairly valued at current levels. They have retained their hold rating on the toll road operator's shares with a trimmed price target of $4.74. The broker said: "Forecast of ALX free cashflow and cash reserves is downgraded (but we still see ALX as capable of sustaining the current DPS of 40 cps until at least the end of the decade). DCF-based business-as-usual valuation of ALX reduces 30 cps to $4.43/sh, due to the forecast changes. 12 month target price (which includes a mild premium for potential takeover activity) declines 31 cps to $4.74/sh."

The post 5 things to watch on the ASX 200 on Monday appeared first on The Motley Fool Australia.

Let's find out why. 

What is Atlas Arteria?

Atlas Arteria is a global owner, operator, and developer of toll roads. It has a portfolio of five toll roads in France, Germany, and the United States. The company was created out of the reorganisation of Macquarie Infrastructure Group in 2010. 

This ASX industrials stock has experienced some volatility in the last 6 months. 

Its stock price has fluctuated between $5.50 and $4.75. 

It closed last week at $4.86. 

However, in a recent note out of Morgans, the broker has updated its guidance on this ASX industrials stock. This was alongside a decreased price target. 

Looking big picture

Morgans have made slight adjustments to forecasts ahead of Atlas Arteria's FY25 result due to be released on 26 February. 

These changes were made due to newer traffic data, inflation updates, FX moves, and a few financing/toll tweaks across ALX's assets.

APRR, the French toll road business, saw slight earnings downgrades as lower inflation will lead to smaller toll increases than previously expected, along with some tax-related adjustments.

At Dulles Greenway in the US, earnings have been upgraded in the short term, but the long-term outlook has been trimmed because future toll increases will be lower than Morgans had previously assumed.

The Chicago Skyway also saw a modest improvement in earnings, although this was partly offset by higher borrowing costs.

The assumption adjustments result in earnings downgrades for APRR, FY25-26 upgrades for Dulles Greenway (but long term downgrades), and mild upgrades for the Chicago Skyway. Forecast of ALX free cashflow and cash reserves is downgraded (but we still see ALX as capable of sustaining the current DPS of 40 cps until at least the end of the decade).

Is there any upside for this ASX industrials stock?

Based on this guidance, Morgans 12 month target price (which includes a mild premium for potential takeover activity) declined 31 cps to $4.74. 

Based on last week's closing price, it seems Atlas Arteria shares are trading close to fair value. 

The updated price target indicates a downside of just over 2.4%. 

Elsewhere, TradingView has an average one year price target of $5.26. 

This indicates approximately 8% upside from current levels. 

It is worth reminding investors this ASX industrials stock also is expected to is pay unfranked dividend yield of more than 8% this year.

The post Why did Morgans just downgrade its view on this ASX industrials stock? appeared first on The Motley Fool Australia.

I've run the ruler over a few companies on the ASX, and come up with three investment ideas which might fit the bill if a decent dividend yield is what you're after.

Poised for broad-based growth

The first of these is McMillan Shakespeare Ltd (ASX: MMS), which, according to the ASX, is paying a trailing dividend yield of 8.7%, fully franked.

The company's products include salary packaging, novated leasing, fleet management, and National Disability Insurance Scheme plans, with more than 500,000 customers on its books.

The company has been growing its earnings year on year for the past three years, while revenue for FY25 was up 3% to $541.6 million.

The company has a policy of paying out 70% to 100% of underlying net profit, and its guidance for the current financial year is for "customer growth across all segments''.

McMillan Shakespeare paid a 77-cent dividend in September, following a 71-cent payout in March.

Taking flight

Second cab off the rank is travel company Helloworld Travel Ltd (ASX: HLO), which is paying a trailing dividend yield of 7.67% fully franked.

The company has paid a consistent 6 cents per share final dividend over the past three years, while in March it paid an outsized interim dividend of 8 cents per share.

Managing Director Andrew Burnes told the company's annual general meeting in October that the company increased its net profit by 4.1% to $33.2 million, despite an 8.7% decline in revenue to $192.8 million.

On the outlook, Mr Burnes said the company's balance sheet was strong, with cash of $79.4 million and no external bank debt.

He added the company was "well-positioned for sustainable growth and long-term resilience", while EBITDA was expected to grow from $60.6 million in FY25 to $64-$72 million this year.

Helloworld is also aiming to buy out fellow listed travel company Webjet Group Ltd (ASX: WJL) with a non-binding bid of 90 cents per share currently in the market.

Road to riches

Our third decent dividend player is toll road operator Atlas Arteria Ltd (ASX: ALX), which is paying a trailing, unfranked dividend yield of 8.24%.

In releasing its first-half results in August, the company said it was not only reaffirming its 40 cents per share dividend, but also said "Atlas Arteria is targeting future distributions of at least 40 cents per share, supported by growing free cash flow''.

Chief Executive Hugh Webby said while releasing the results that, "by staying disciplined on managing capital and costs efficiently and being relentless about performance, we're setting ourselves up to keep delivering long-term value for our securityholders''.

The post Three under-the-radar dividend plays for your portfolio appeared first on The Motley Fool Australia.

Then you might want to have a look into international toll road operator and developer Atlas Arteria Ltd (ASX: ALX).

That's according to the analysts at Macquarie Group Ltd (ASX: MQG), who just reiterated their outperform rating on Atlas Arteria shares.

Atlas Arteria shares closed up 1.4% on Thursday, trading for $4.99 apiece.

On the passive income front, the ASX 200 dividend stock paid out 40 cents per share in unfranked dividends over the past full year. That sees the stock trading on an unfranked trailing dividend yield of 8.0%.

Atlas Arteria shares are down 0.2% over 12 months, with the stock having gained 4.6% in 2025.

Looking to the year ahead, Macquarie expects investors will enjoy a materially better share price performance atop those welcome dividends.

Here's why.

ASX 200 dividend stock tipped to outperform

Atlas Arteria released its third quarter (Q3 2025) update on Wednesday.

Among the highlights, the ASX 200 dividend stock reported a 10.9% year-on-year increase in proportionate toll revenue for the three months ending 30 September.

The company credited the increase to "strong" traffic growth across its global portfolio of toll roads.

"At Dulles Greenway, increased congestion on competing routes supported continued traffic strength," the company noted said.

Commenting on that result, Macquarie noted:

Greenway's traffic growth is accelerating. This is consistent with DTR (+~8%), I-95 (+9%) and I495 (+5%), as congestion rebuilds to pre-2020 levels. Price application this quarter – we expect at 20-25% – becomes lower risk as traffic surges.

With discussion with SCC, VDOT and Loudoun County as a precursor to the application, we anticipate less resistance to a sensible claim. Success provides a pathway for cashflow from the asset.

Atlas Arteria also highlighted one its other US-based assets, stating:

Chicago Skyway traffic also grew as commuters took to the road over summer, with heavy vehicle traffic also improving relative to Q2. Proportionate toll revenue was positively impacted by toll increases as well as beneficial movements in foreign exchange rates.

Amid expectations that France will rollover the Temporary Supplemental Tax that Atlas Arteria's French operations recently got slugged with, Macquarie lowered its 12-month price target for the ASX 200 dividend stock to $5.55 a share, down from the prior $5.64.

That still represents a potential upside of 11.2% from Thursday's closing price. And it doesn't include the two upcoming 2026 dividend payouts.

The post This ASX 200 dividend stock yields 8% AND is tipped for share price gains appeared first on The Motley Fool Australia.

What did Atlas Arteria report?

• Distribution declared: 20.0 Australian cents per stapled security (unfranked) for H1 FY25
• Ex-entitlement date: 24 September 2025
• Record date: 25 September 2025
• Estimated payment date: 7 October 2025

What else do investors need to know?

The distribution will be paid jointly by Atlas Arteria and Atlas Arteria International. Security holders should note the payment is unfranked.

Atlas Arteria's investment portfolio includes toll road assets across France, Germany, and the United States. The group maintains interests in strategic motorway networks, including APRR in France, Chicago Skyway and Dulles Greenway in the US, and the Warnow Tunnel in Germany.

Investors are encouraged to review tax treatment details on the company's website, as distributions may have different implications depending on your location.

What's next for Atlas Arteria?

Atlas Arteria will continue its focus on managing and optimising its global portfolio of toll road assets, supporting long-term value for stakeholders. The business remains committed to delivering dependable distributions while applying disciplined and sustainable management practices.

Shareholders can expect the distribution payment in early October, with future updates likely as the company executes its strategy across key international markets.

Atlas Arteria share price snapshot

Atlas Arteria shares have risen 11% for the year to date, outpacing the S&P/ASX 200 Index (ASX: XJO) which has increased 7% over the same period.

View Original Announcement

The post Atlas Arteria announces interim H1 2025 distribution appeared first on The Motley Fool Australia.

Shares in the international toll road operator and developer closed yesterday trading for $5.22. In afternoon trade on Thursday, shares are changing hands for $5.19 apiece, down 0.5%.

For some context, the ASX 200 is down 0.3% at this same time.

Over the past 12 months, Atlas Arteria shares have underperformed the benchmark, slipping 1.0%.

Though that's not including the 40 cents per share in unfranked dividends the company paid out over the full year. At the current share price (at time of writing), this sees the ASX 200 dividend stock trading on a juicy trailing yield of 7.7%.

Turning to the year ahead, atop the passive income on offer, the team at Macquarie Group Ltd (ASX: MQG) has an outperform rating on Atlas Arteria shares.

Here's why.

ASX 200 dividend stock tipped to outperform

Atlas Arteria released its second quarter (Q2 2025) update on Wednesday.

Investors bid up the ASX 200 dividend stock, with the company reporting a 10.7% year-on-year increase in proportionate toll revenue for the three months ending 30 June. Toll revenue was up 8.1% year to date.

Management said that proportionate toll revenue was boosted by toll increases alongside positive movements in foreign exchange rates.

Indeed, Macquarie noted that a weaker Aussie dollar is positive for the company's valuation.

Atlas Arteria owns toll road concessions in France, the United States, and Germany.

Drilling into its assets, Macquarie noted:

Its largest asset is a 31% stake in the APRR toll road network in France, a 2,318 kilometre inter-city road network with concession expiring in 2035. In the US, ALX owns the Dulles Greenway, a commuter toll road connecting to Washington DC, with concession expiring in 2056. In Germany, ALX owns the Warnow Tunnel, connecting the city of Rostock through a river crossing.

Looking at its biggest asset, Macquarie said, "APRR traffic was positive at +3% for the quarter, which was anticipated with strong Easter holidays, albeit still ahead of expectations."

And the months ahead could also see the ASX 200 dividend stock beat consensus expectations.

"We believe the summer has also started well based off [French toll road operator] SANEF numbers which results in minor revenue improvements in our expectations," Macquarie said.

The broker raised its price target for Atlas Arteria shares from $5.51 to $5.78, with an outperform rating.

That represents a potential share price gain of 11.4% from current levels.

And it doesn't include the market-beating passive income on offer from the high-yielding ASX 200 dividend stock.

The post Why Macquarie expects this high-yielding ASX 200 dividend stock to outperform appeared first on The Motley Fool Australia.